Development of potential preclinical candidates with promising in vitro ADME profile for the inhibition of type 1 and type 2 17β-Hydroxysteroid dehydrogenases: Design, synthesis, and biological evaluation
- 1 September 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 178, 93-107
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (031A467)
- Deutsche Forschungsgemeinschaft (FR 3002/1-1)
This publication has 43 references indexed in Scilit:
- Sex Steroids and Bone Health Status in MenInternational Journal of Endocrinology, 2012
- Overexpression of 17β-Hydroxysteroid Dehydrogenase Type 1 Increases the Exposure of Endometrial Cancer to 17β-EstradiolThe Journal of Clinical Endocrinology & Metabolism, 2012
- Bicyclic Substituted Hydroxyphenylmethanones as Novel Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) for the Treatment of Estrogen-Dependent DiseasesJournal of Medicinal Chemistry, 2010
- Novel Hydroxysteroid (17β) Dehydrogenase 1 Inhibitors Reverse Estrogen-Induced Endometrial Hyperplasia in Transgenic MiceThe American Journal of Pathology, 2010
- Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosisGynecological Endocrinology, 2007
- Role of RANKL inhibition in osteoporosisArthritis Research & Therapy, 2007
- Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzymeMolecular and Cellular Endocrinology, 2006
- Androgenic and estrogenic 17β-hydroxysteroid dehydrogenase/17-ketosteroid reductase in human ovarian epithelial tumors: evidence for the type 1, 2 and 5 isoformsThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Synthesis and In Vitro Evaluation of 3‐(1‐Azolylmethyl)‐1H‐indoles and 3‐(1‐Azolyl‐1‐phenylmethyl)‐1H‐indoles as Inhibitors of P450 aromArchiv der Pharmazie, 1997
- INACTIVATION OF THE BIOLOGICAL EFFECTS OF EXOGENOUS AND ENDOGENOUS ESTROGENS BY ANTIBODIES TO 17β-ESTRADIOLObstetrical & Gynecological Survey, 1969